Concepedia

Michal Dwojak

MD

Statistics

Publications

6

Citations

149

H-Index

6

Active since

2012

Affiliations

Medical University of Warsaw(Current)

Postgraduate School of Molecular Medicine

Central Clinical Hospital

National Center for Tumor Diseases

Instytut Hematologii i Transfuzjologi

Michal Dwojak is an author at Medical University of Warsaw specializing in molecular oncology, anti-cd20 antibody therapy, and anti-cd20 therapy.

Publications per year

2012–2020

6

Publications

6

HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies

Małgorzata Bobrowicz, Michal Dwojak, Beata Pyrzyńska et al. · Blood · 2017 · 52 citations · Full text

, , +13

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Beata Pyrzyńska, Michal Dwojak, Abdessamad Zerrouqi et al. · OncoImmunology · 2018 · 34 citations · Full text

, , +15

Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity

Magdalena Winiarska, Dominika Nowis, Jacek Bil et al. · Journal of Biological Chemistry · 2012 · 21 citations · Full text

, , +10

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies

Magdalena Winiarska, Kamil Bojarczuk, Beata Pyrzyńska et al. · mAbs · 2014 · 20 citations · Full text

, , +17

Selection of an optimal promoter for gene transfer in normal B cells

Magdalena Winiarska, Dominika Nowis, Małgorzata Firczuk et al. · Molecular Medicine Reports · 2017 · 11 citations · Full text

, , +15

1–5 of 6